Aktieanalys

Q-linea: A US launch is in sight - Redeye

Redeye Publicerad: 29 Apr 09:29

Q-linea has secured a US FDA approval, which is positive. We look forward to Q-linea providing an update and more details regarding the US launch. Q-linea has limited financial flexibility and natural questions and alternatives could include a targeted regional launch, possibly with a commercial partner. We have not made any changes at this stage, and our later Base Case ahead of Q1 is SEK 6 (Bull 20 and Bear SEK 1). Q-linea has scheduled the Q1 report to May 17th 2024.

Länk till analysen i sin helhet: https://www.redeye.se/research/1001198/q-linea-a-us-launch-is-in-sight?utm_source=finwire&utm_medium=RSS

Nyheter om Q-Linea

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!